Streetbeat News

Revenues

MGY

Magnolia Oil & Gas (MGY) reported Q1 earnings of $0.46 per share, meeting analyst estimates, with a 25.81% decrease from last year. Sales were $319.42M, beating estimates by 3.70% and marking a 3.58% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:02 pm

PCRX

Pacira BioSciences (NASDAQ:PCRX) reported Q1 2024 adjusted earnings of $0.62 per share, meeting analyst estimates, with sales of $167.117M surpassing the $165.351M forecast, marking a 4.23% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:02 pm

WMT

21 analysts have recently reviewed Walmart (NYSE:WMT), showing a mix of bullish to bearish sentiments, with a majority leaning towards bullish. The average 12-month price target is now $132.37, down 11.06% from the previous $148.83. Analyst actions vary, with some raising and others lowering their price targets, reflecting ongoing adjustments based on Walmart's performance and market conditions. Walmart's financial overview indicates strong revenue growth, profitability, and effective debt management, positioning it favorably in the market.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 8:01 pm

FAST

Six analysts have recently updated their ratings on Fastenal (NASDAQ:FAST), showing a mix of neutral and positive outlooks. The average 12-month price target is now $72.00, up from $71.17, with a high estimate of $85.00 and a low of $64.00. Analyst actions include both upgrades and downgrades, reflecting varied perspectives on the company's performance and market conditions. Fastenal's financials indicate strong profitability and efficient asset and equity management, with a notable market capitalization and revenue growth, although slightly lagging behind industry peers.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 8:01 pm

AAPL

BRK

BofA Securities analyst Wamsi Mohan reiterated a Buy rating on Apple Inc (AAPL) with a price target of $230, highlighting Apple's largest share buyback authorization of $110 billion and a 4% dividend increase. Warren Buffett's Berkshire Hathaway reduced its stake in Apple, citing tax reasons but expects it to remain its largest holding. Apple's gross margin and services momentum are seen positively, despite a decline in operating margins in China. Apple faces EU and DoJ legal challenges but plans to defend itself vigorously. Apple's manufacturing purchase commitments and inventory declined, but it returned $27.3 billion to shareholders in Q2.

Portfolio Pulse from Anusuya Lahiri

May 07, 2024 | 8:01 pm

CPNG

Coupang reported Q1 earnings of $0.05 per share, missing the consensus estimate of $0.06, and sales of $7.11B, beating the estimate of $6.91B. This represents a 22.66% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:01 pm

NGVT

Ingevity (NYSE:NGVT) received mixed analyst ratings in the last quarter, with a shift towards a more cautious stance in the last 30 days. The average 12-month price target for NGVT has been raised to $56.5, reflecting a 16.49% increase from the previous target. Analysts from Loop Capital, Oppenheimer, Jefferies, and Wells Fargo have all raised their price targets, indicating a positive outlook on the stock despite the company facing challenges such as a -13.37% decline in revenue growth and a high debt-to-equity ratio of 2.74.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 8:00 pm

CLDX

In the latest quarter, Celldex Therapeutics (NASDAQ:CLDX) received mixed analyst ratings, with an updated average 12-month price target of $79.25, reflecting a 10.07% increase from the previous target. The company, engaged in developing immunotherapy technologies, showed a significant revenue growth of 156.11% as of December 31, 2023, but struggles with profitability, indicated by a net margin of -1048.32%. Analysts from HC Wainwright & Co., Cantor Fitzgerald, and Guggenheim provided insights, with one raising the price target to $90.00.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 8:00 pm

LYV

Live Nation Entertainment Inc (NYSE:LYV) is preparing to discuss with the DOJ's senior division leadership regarding a lawsuit that challenges the merger between Live Nation and Ticketmaster. CFO Joe Berchtold expressed confidence that a breakup is not a legally permissible outcome. Despite facing potential antitrust litigation and a class action lawsuit from investors, Live Nation reported a 21% increase in Q1 revenue, indicating strong concert demand.

Portfolio Pulse from Aaron Bry

May 07, 2024 | 7:53 pm

TRTX

TPG RE Finance Trust (NYSE:TRTX) received mixed ratings from 5 analysts, with recent updates showing a shift towards more bullish perspectives. The average 12-month price target was raised to $7.7, indicating a 15.44% increase from the previous target. Analysts from Wells Fargo, Raymond James, JP Morgan, and B of A Securities adjusted their ratings and price targets, reflecting varied expectations for TRTX's performance. The company's financial indicators, such as revenue growth, net margin, ROE, and ROA, outperform industry averages, suggesting strong financial health and efficient management.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:01 pm